Comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay

The present study was performed to compare the bioavailability of two digoxin 0.25 mg tablet formulation in 30 volunteers of both sexes. The study was conducted open with randomized two period crossover design and a three-week washout period. Plasma samples were obtained over a 144 h interval. Digox...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junior, Eduardo A., Duarte, Luciana F., Vanunci, Moisés L. P., Silva, Lara C., Pereira, Renata, Calafatti, Silvana, Junior, José P.
Formato: Articulo Comunicacion
Lenguaje:Inglés
Publicado: 2011
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/8288
http://www.latamjpharm.org/resumenes/30/6/LAJOP_30_6_2_7.pdf
Aporte de:
id I19-R120-10915-8288
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Farmacia
bioequivalence; digoxin; pharmacokinetics; volunteers
Farmacocinética
Glicósidos Cardíacos
Inmunoensayo
spellingShingle Farmacia
bioequivalence; digoxin; pharmacokinetics; volunteers
Farmacocinética
Glicósidos Cardíacos
Inmunoensayo
Junior, Eduardo A.
Duarte, Luciana F.
Vanunci, Moisés L. P.
Silva, Lara C.
Pereira, Renata
Calafatti, Silvana
Junior, José P.
Comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay
topic_facet Farmacia
bioequivalence; digoxin; pharmacokinetics; volunteers
Farmacocinética
Glicósidos Cardíacos
Inmunoensayo
description The present study was performed to compare the bioavailability of two digoxin 0.25 mg tablet formulation in 30 volunteers of both sexes. The study was conducted open with randomized two period crossover design and a three-week washout period. Plasma samples were obtained over a 144 h interval. Digoxin concentrations were analyzed by a validated microparticle enzyme immunoassay with optical detection by fluorescence. Bioequivalence between the products was determined by calculating 90 % confidence intervals (90 % I.C) for the ratio of AUC<sub>0-72h</sub> and C<sub>max</sub> values for the test and reference products, using logarithmic transformed data. The 90 % confidence intervals were 86.98-118.33 %, and 84.52–98.76 %, respectively. Since the 90 % confidence intervals for C<sub>max</sub> and AUC<sub>0-72h</sub> were within the 80-125 % interval proposed by Food and Drug Administration, it was concluded that the two Digoxin formulations are bioequivalent in their rate and extent of absorption.
format Articulo
Comunicacion
author Junior, Eduardo A.
Duarte, Luciana F.
Vanunci, Moisés L. P.
Silva, Lara C.
Pereira, Renata
Calafatti, Silvana
Junior, José P.
author_facet Junior, Eduardo A.
Duarte, Luciana F.
Vanunci, Moisés L. P.
Silva, Lara C.
Pereira, Renata
Calafatti, Silvana
Junior, José P.
author_sort Junior, Eduardo A.
title Comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay
title_short Comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay
title_full Comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay
title_fullStr Comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay
title_full_unstemmed Comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay
title_sort comparative bioavailability of two digoxin formulations: determination in human plasma by microparticle enzyme immunoassay
publishDate 2011
url http://sedici.unlp.edu.ar/handle/10915/8288
http://www.latamjpharm.org/resumenes/30/6/LAJOP_30_6_2_7.pdf
work_keys_str_mv AT junioreduardoa comparativebioavailabilityoftwodigoxinformulationsdeterminationinhumanplasmabymicroparticleenzymeimmunoassay
AT duartelucianaf comparativebioavailabilityoftwodigoxinformulationsdeterminationinhumanplasmabymicroparticleenzymeimmunoassay
AT vanuncimoiseslp comparativebioavailabilityoftwodigoxinformulationsdeterminationinhumanplasmabymicroparticleenzymeimmunoassay
AT silvalarac comparativebioavailabilityoftwodigoxinformulationsdeterminationinhumanplasmabymicroparticleenzymeimmunoassay
AT pereirarenata comparativebioavailabilityoftwodigoxinformulationsdeterminationinhumanplasmabymicroparticleenzymeimmunoassay
AT calafattisilvana comparativebioavailabilityoftwodigoxinformulationsdeterminationinhumanplasmabymicroparticleenzymeimmunoassay
AT juniorjosep comparativebioavailabilityoftwodigoxinformulationsdeterminationinhumanplasmabymicroparticleenzymeimmunoassay
bdutipo_str Repositorios
_version_ 1764820488723365888